0,5% Eprinomectin effundam in solution
.png)
.png)
.png)
.png)
Pharmacological actio
Eprinomectinbelongs to macrolide insecticides, which have a highly effective anthelmintic effect on internal and external parasites, especially nematodes and arthropods, by increasing the release of γ-aminobutyric acid (γ-GABA), an inhibitory transmitter of the parasite, as well as opening glutamate-controlled chloride channels, enhancing the permeability of the nerve membrane to chloride ions so as Ad angustos ad transmissionem neruum annuit, ultimate ad nervi paralysis parasitus et damnum contractile facultatem musculi cellulis et mortis.
Pharmacological actio
EprinomectinEst solutum, et Pharmacokinetics Show nonlinear characteres. Cum 0.5 mg / kg · bw infudit in tergo de dairy vaccas, apicem concentration (CMAX) erat 18.64 ± 2.51 NG / MRT in AUC01 Dies ML Dies, ARGENTUM AUC01 Dies 0.45) 113,90 Dies in AUC0-0.45) 113,90 in AUC00-0.45) 113,90 in AUC00-0.45), in area in area (auc0-0.45) 113,90 in AUC00-0.45) 113,90 et in tempore, 0.61, 0.45, in area, in area, 0.92. Apparent volumine distribution (VD) XLI L, Plasma Clearance (C) 4,5 l / die, maxime excernitur in faecibus, et parva moles excernitur in lac et urina.
Indicium
Eprinomectin effundam in solution adhibetur ad curatio of parasitic morbo ut nematodes et minuta in vitro in dairy vaccas.
Dosis et Administration
Calculus initus ut Eprinomectin. Externum usum, paulatim effundam 0,5 mg pecoris per I kg corporis pondus per dorsales iugum de lacticiniis vaccas ex clavus ad basim in cauda (id est, I ml huius uber per X kg corporis pondus).
Cautiones
I. Nam externa in iumentis tantum. Non applicare ad areas de cutis cum scabie, cutis laesiones, luto et feces.
II. Si productum est gelida, ut sit totaliter EDUCULUS et commovebitur tam ante usum.
III. Vitare nuditate pueri pharmaca.
IV. Usus medicamento utres et RELICTUM medicamento liquidum erit tuto disposita (ut sepultura).
Adversa reactiones
Cum usus ad certum dose, nec adversa reactiones sunt observata.
Recessum tempus
0 diebus.
Sarcina
200ml / Utrem, 1l / Utrem, 2L / Utrem, 5L / Utrem
Repono
Stored in Storeptus Condition infra XXX ℃, protected ex lumine.
Hebei veyong pharmaceutical Co., Ltd, erat statutum in MMII, sita in Shijiazhuang urbem, Hebei provinciam, Sina, deinde ad caput Beijing. Ea est magna GMM-certified VETERINARIUS ENTERIPRISE, cum R & D, productio et Sales VETERINARIUS APIS, Praeparata, premixed feeds et feed additives. Ut Provincialis Technical Center, Veyong constituit in novam R & D System pro nova VETERINARIUS medicamento, quod est nationaliter notum technicae innovation secundum VETERINARIUS Enterprise, sunt LXV technica professionals. Veyong habet duas productionem bases: Shijiazhuang et Ordos, de quibus Shijiazhuang basi opercula in area 78.706 M2, cum XIII API, et XI Production Productio, Premix, PRESTATUS, Bolus, Pesicid disinfectant, rectae. Veyong praebet apis, magis quam C own- label apparatu, et OEM & ODM Service.
Veyong attaches magni momenti ad administratione EHS (environment, salutem & salus) systema, et adeptus est ISO14001 et Ohsas18001 testimoniales. Veyong est enumerantur in opportuna emergentes Industrial conatibus in Hebei provinciae et can continua copia products.
Veyong statutum est completum qualitas administratione ratio, adeptus est ISO9001 Certificate, Sinis GMP Certificatorium, Australia APVMA GMP CEP CEP certificatorium, et US FDE. Veyong habet professional quadrigis de Registerationis, Sales et technica Service, nostri comitatu lucrata confidunt et subsidium a numerosis customers per optimum productum qualis, summus qualitas pre-venditio et post-venditionesque servitium, gravi et scientific administratione. Veyong fecit diu terminus cooperante cum multis internationally nota animal pharmaceutical conatibus cum products exportata ad Europam, Meridionalis America, Medius Oriente, Africa et regiones, etc.
